Author

Fabricio Montero Zuniga

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

Amaury VaysseiD· 1 shared Andrew N.J. TuttiD· 1 shared Aurélien BoreiD· 1 shared Christopher J. LordiD· 1 shared Daniel González‐AcostaiD· 1 shared Dragomir B. KrasteviD· 1 shared Fei SongiD· 1 shared François DossiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amaury VaysseORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular CellPeer-reviewedOct 1, 2026

The FANCM-RMI1/2 complex promotes genomic instability and PARP inhibitor sensitivity in BRCA2-deficicient cells.

François Dossin, Mikaël Attia, Fabricio Montero Zuniga…·Ludovic Deriano

This study identifies FANCM-RMI1/2 as a driver of PARP inhibitor sensitivity in BRCA2-deficient cells, revealing distinct adaptation mechanisms between BRCA1 and BRCA2 loss.

DOI 10.1016/j.molcel.2026.09.017

mouseexperimental assay

𝕏 PostBluesky